Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：955

作者：

Escudier, B. ^{[1
]}

Porta, C. ^{[2
,3
]}

Schmidinger, M. ^{[4
,5
]}

Rioux-Leclercq, N. ^{[6
,7
]}

Bex, A. ^{[8
,9
]}

Khoo, V. ^{[10
,11
,12
]}

Grunwald, V. ^{[13
,14
]}

Gillessen, S. ^{[15
,16
,17
]}

Horwich, A. ^{[18
]}

机构：

[1] Gustave Roussy, Dept Med Oncol, Villejuif, France

[2] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy

[3] IRCCS Ist Clin Sci Maugeri, Div Translat Oncol, Pavia, Italy

[4] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria

[5] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria

[6] Rennes Hosp, Dept Pathol, Rennes, France

[7] Univ Rennes, Rennes, France

[8] Royal Free Hosp, Specialist Ctr Kidney Canc, UCL Div Surg & Intervent Sci, London, England

[9] Netherlands Canc Inst, Div Surg Oncol, Amsterdam, Netherlands

[10] Royal Marsden Hosp, Inst Canc Res, Dept Clin Oncol, London, England

[11] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

[12] Monash Univ, Clayton, Vic, Australia

[13] Univ Hosp Essen, West German Canc Ctr, Internal Med Tumour Res & Clin Urol, Essen, Germany

[14] Univ Hosp Essen, West German Canc Ctr, Urol Clin, Essen, Germany

[15] Univ Manchester, Div Canc Sci, Manchester, Lancs, England

[16] The Christie, Manchester, Lancs, England

[17] Kantonsspital St Gallen, Div Oncol & Haematol, St Gallen, Switzerland

[18] Royal Marsden Hosp, Sutton Hosp, Inst Canc Res, Dept Acad Radiotherapy, Sutton, Surrey, England

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷 / 05期

关键词：

PHASE-III; DOUBLE-BLIND; OPEN-LABEL; ACTIVE SURVEILLANCE; ADJUVANT SUNITINIB; SURGICAL RESECTION; TARGETED THERAPY; INTERFERON-ALPHA; HIGH-RISK; EVEROLIMUS;

D O I：

10.1093/annonc/mdz056

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：706 / 720

页数：15

共 70 条

[1]

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].

Andrews, DW ;

Scott, CB ;

Sperduto, PW ;

Flanders, AE ;

Gaspar, LE ;

Schell, MC ;

Werner-Wasik, M ;

Demas, W ;

Ryu, J ;

Bahary, JP ;

Souhami, L ;

Rotman, M ;

Mehta, MP ;

Curran, WJ .

LANCET, 2004, 363 (9422) :1665-1672

[2]

[Anonymous], EUR UROL FOCUS

[3]

[Anonymous], IUCC TNM CLASSIFICAT

[4]

Coffee consumption and risk of renal cell carcinoma [J].

Antwi, Samuel O. ;

Eckel-Passow, Jeanette E. ;

Diehl, Nancy D. ;

Serie, Daniel J. ;

Custer, Kaitlynn M. ;

Arnold, Michelle L. ;

Wu, Kevin J. ;

Cheville, John C. ;

Thiel, David D. ;

Leibovich, Bradley C. ;

Parker, Alexander S. .

CANCER CAUSES & CONTROL, 2017, 28 (08) :857-866

[5]

TFEB-amplified Renal Cell Carcinomas An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity [J].

Argani, Pedram ;

Reuter, Victor E. ;

Zhang, Lei ;

Sung, Yun-Shao ;

Ning, Yi ;

Epstein, Jonathan I. ;

Netto, George J. ;

Antonescu, Cristina R. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (11) :1484-1495

[6]

Everolimus versus sunitinib for patients with metastatic non-clear-cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial [J].

Armstrong, Andrew J. ;

Halabi, Susan ;

Eisen, Tim ;

Broderick, Samuel ;

Stadler, Walter M. ;

Jones, Robert J. ;

Garcia, Jorge A. ;

Vaishampayan, Ulka N. ;

Picus, Joel ;

Hawkins, Robert E. ;

Hainsworth, John D. ;

Kollmannsberger, Christian K. ;

Logan, Theodore F. ;

Puzanov, Igor ;

Pickering, Lisa M. ;

Ryan, Christopher W. ;

Protheroe, Andrew ;

Lusk, Christine M. ;

Oberg, Sadie ;

George, Daniel J. .

LANCET ONCOLOGY, 2016, 17 (03) :378-388

[7]

Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations [J].

Becker, Frank ;

Junker, Kerstin ;

Parr, Martin ;

Hartmann, Arndt ;

Fuessel, Susanne ;

Toma, Marieta ;

Grobholz, Rainer ;

Pflugmann, Thomas ;

Wullich, Bernd ;

Strauss, Arne ;

Behnes, Carl Ludwig ;

Otto, Wolfgang ;

Stoeckle, Michael ;

Jung, Volker .

PLOS ONE, 2013, 8 (10)

[8]

Bex A, 2019, JAMA ONCOL, V5, P164, DOI 10.1001/jamaoncol.2018.5543

[9]

ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma [J].

Brooks, Samira A. ;

Brannon, A. Rose ;

Parker, Joel S. ;

Fisher, Jennifer C. ;

Sen, Oishee ;

Kattan, Michael W. ;

Hakimi, A. Ari ;

Hsieh, James J. ;

Choueiri, Toni K. ;

Tamboli, Pheroze ;

Maranchie, Jodi K. ;

Hinds, Peter ;

Miller, C. Ryan ;

Nielsen, Matthew E. ;

Rathmell, W. Kimryn .

EUROPEAN UROLOGY, 2014, 66 (01) :77-84

[10]

Molecular Genetics of Clear-Cell Renal Cell Carcinoma [J].

Brugarolas, James .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) :1968-+

← 1 2 3 4 5 6 7 →